Mixed potassium-manganese vanadate-carbonate, K(2)Mn(3)(VO(4))(2)(CO(3)), represents a novel structure type; it has been synthesized hydrothermally from the system MnCl(2)-K(2)CO(3)-V(2)O(5)-H(2)O. Its hexagonal crystal structure was determined by single-crystal X-ray diffraction with a = 5.201(1) Å, c = 22.406(3) Å, space group P6(3)/m, Z = 2, ρ(c) = 3.371 g/cm(3), and R = 0.022. The layered structure of the compound can be described as a combination of honeycomb-type modules of [MnO(6)] octahedra and [VO(4)] tetrahedra, alternating in the [001] direction with layers of [MnCO(3)] built by [MnO(5)] trigonal bipyramids and [CO(3)] planar triangles, sharing oxygen vertices. The K(+) ions are placed along channels of the framework, elongated in the [100], [010], and [110] directions. The title compound exhibits rich physical properties reflected in a phase transition of presumably Jahn-Teller origin at T(3) = 80-100 K as well as two successive magnetic phase transitions at T(2) = 3 K and T(1) = 2 K into a weakly ferromagnetic ground state, as evidenced in magnetization, specific heat, and X-band electron spin resonance measurements. A negative Weiss temperature Θ = -114 K and strongly reduced effective magnetic moment μ(eff)(2) ~ 70 μ(B)(2) per formula unit suggest that antiferromagnetic exchange interactions dominate in the system. Divalent manganese is present in a high-spin state, S = 5/2, in the octahedral environment and a low-spin state, S = ½, in the trigonal-bipyramidal coordination.
The system Cs2−xRbxSnCu3F12 exhibits several different distorted variants of the kagome lattice, which are probed in detail by powder diffraction methods.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.